Konety B - Search Results

1

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging.

de Almeida S R Jr, Thomas J, Mason MM, Becerra MF, Merhe A, Reis IM, Kwon D, Soodana-Prakash N, Tewari A, Patel V, Wagaskar V, Konety B, Kasraeian A, Czarniecki S, Thoreson GR, Kim EH, Swain S, Parekh DJ, Punnen S. de Almeida S R Jr, et al. Among authors: konety b. BJUI Compass. 2023 May 1;4(5):591-596. doi: 10.1002/bco2.235. eCollection 2023 Sep. BJUI Compass. 2023. PMID: 37636212 Free PMC article.

2

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.

Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etzioni R, Fine SW, Han M, Kim SK, Kirkby E, Konety BR, Miner M, Moses K, Nissenberg MG, Pinto PA, Salami SS, Souter L, Thompson IM, Lin DW. Wei JT, et al. J Urol. 2023 Jul;210(1):54-63. doi: 10.1097/JU.0000000000003492. Epub 2023 Apr 25. J Urol. 2023. PMID: 37096575

3

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid 2022;1:EVIDoa2200092.

Sussman J, Konety B, Ahmadi H. Sussman J, et al. Among authors: konety b. Eur Urol. 2024 Feb;85(2):178-179. doi: 10.1016/j.eururo.2023.07.017. Epub 2023 Aug 12. Eur Urol. 2024. PMID: 37580211 Clinical Trial. No abstract available.

4

Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the Restore -2 study.

Bates AJ, Mitteldorf D, Rosser BRS, Wheldon CW, Polter EJ, Ross MW, Talley KMC, Haggart R, Wright MM, West W, Konety BR. Bates AJ, et al. Among authors: konety br. BMJ Mil Health. 2024 Mar 28:e002649. doi: 10.1136/military-2023-002649. Online ahead of print. BMJ Mil Health. 2024. PMID: 38548328

5

Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?

Sathianathen NJ, Lawrentschuk N, Konety B, Azad AA, Corcoran NM, Bolton DM, Murphy DG. Sathianathen NJ, et al. Among authors: konety b. Eur Urol Oncol. 2023 Dec 5:S2588-9311(23)00278-X. doi: 10.1016/j.euo.2023.11.013. Online ahead of print. Eur Urol Oncol. 2023. PMID: 38057191 Free article.

6

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.

Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etzioni R, Fine SW, Han M, Kim SK, Kirkby E, Konety BR, Miner M, Moses K, Nissenberg MG, Pinto PA, Salami SS, Souter L, Thompson IM, Lin DW. Wei JT, et al. J Urol. 2023 Jul;210(1):46-53. doi: 10.1097/JU.0000000000003491. Epub 2023 Apr 25. J Urol. 2023. PMID: 37096582

7

Unrecognized sexual dysfunction in gay and bisexual men after prostate cancer treatment: the antecedents and impact of anodyspareunia.

Wheldon CW, Bates AJ, Polter EJ, Rosser BRS, Kapoor A, Talley KMC, Haggart R, Kohli N, Konety BR, Mitteldorf D, Ross MW, West W, Wright M. Wheldon CW, et al. Among authors: konety br. J Sex Med. 2023 Mar 31;20(4):515-524. doi: 10.1093/jsxmed/qdad009. J Sex Med. 2023. PMID: 36796863 Free PMC article. Clinical Trial.

8

Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection.

Bae SY, Kamalanathan KJ, Galeano-Garces C, Konety BR, Antonarakis ES, Parthasarathy J, Hong J, Drake JM. Bae SY, et al. Among authors: konety br. Endocrinology. 2024 Feb 20;165(4):bqae022. doi: 10.1210/endocr/bqae022. Endocrinology. 2024. PMID: 38366552 Free PMC article. Review.

9

Discrimination of Sexual and Gender Minority Patients in Prostate Cancer Treatment: Results from the Restore-1 Study.

Ross MW, Rosser BRS, Polter EJ, Bates AJ, Wheldon CW, Haggart R, West W, Kohli N, Konety BR, Mitteldorf D, Talley GKMC, Wright M. Ross MW, et al. Among authors: konety br. Stigma Health. 2023 Feb;8(1):85-92. doi: 10.1037/sah0000356. Epub 2022 Jan 20. Stigma Health. 2023. PMID: 36779009 Free PMC article.

10

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.

Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. Among authors: konety br. J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020. Online ahead of print. J Urol. 2024. PMID: 38704840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page